drugset / Trial / NCT00305227

Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection

NCT00305227

RandomizedSingle-groupQuadruple-blindPrevention

Summary

Recurrent urinary tract infections (RUTIS) continue to be a major health problem in women and are now complicated by increasing antibiotic resistance. New preventive approaches are needed. Because most women with RUTI lack the normal protective Lactobacillus (LB) in their vaginal flora, we hypothesized that restoration of LB would reduce RUTIS. In this trail, women with recent UTI are randomized to receive either LB or placebo vaginal capsules and are followed for side effects, for colonization with LB and for occurrence of RUTI over hte next four months.

Timeline

Start
2006-03
Primary completion
2012-04
Completion
2012-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject LACTIN-V Other / unclassified 5e+08 unknown Other